BioSpace News Archive

Business

Oulu University Hospital in Finland Enters Long-Term Strategic Partnership with Varian and Siemens Healthineers

Ten-year strategic partnership is designed to advance the quality of comprehensive cancer care for patients in Northern Finland.

January 19, 2022
·
3 min read
Business

UPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance

Osmotica Pharmaceuticals plc, a specialty pharmaceutical company, announced that the Company has changed its name to RVL Pharmaceuticals plc .

January 19, 2022
·
9 min read
Lone Star Bio

Nanoscope’s Vision Restoring Optogenetic Gene Therapy to be Featured in Four Presentations as part of SPIE Photonics West 2022 in San Francisco Jan. 22-27, 2022

Nanoscope Therapeutics Inc., will be featured in several presentations at BiOS, the world’s largest biomedical optics and biophotonics conference, as a part of SPIE Photonics West 2022, in San Francisco, January 22–27, 2022 at the Moscone Center.

January 19, 2022
·
2 min read
Slide Stainers Market Size To Reach USD 8.02 Billion By 2028, Says Reports And Data

Technological advancements in laboratory infrastructure and surging demand for laboratory automation solutions is bolstering market growth.

January 19, 2022
·
7 min read
Drug Development

AB Science has been granted authorization to initiate Phase II study in patients with severe mast cell activation syndrome by the French Health Authority (ANSM)

AB Science SA (Euronext - FR0010557264 - AB) today announces that it has been authorized by the French Medicine Agency, ANSM, to initiate a Phase II study (AB20006) in patients with severe mast cell activation syndrome.

January 19, 2022
·
6 min read
Apotex Corp. Launches First-to-Market Authorized Generic Version of Combigan Ophthalmic Solution in the United States

Apotex Corp. launched the authorized generic version of Combigan® (Brimonidine Timolol OPSO 0.2%/0.5%) in the United States.

January 19, 2022
·
1 min read
Genetown

Theromics Inc. Announces Closing of Oversubscribed $2M Seed Series and Names John Brooks III to Board of Directors

Theromics Inc., a medical device company pioneering novel technologies for interventional radiology and drug delivery, has closed a $2M seed equity financing to advance the development of HeatSYNC™, a thermal accelerant gel for optimizing and augmenting soft tissue thermal ablations.

January 19, 2022
·
3 min read
Genetown

Entrinsic Bioscience Demonstrates Breakthrough GI Barrier Benefits

Entrinsic Bioscience (EBS), a pioneering life sciences company, announced results from a new clinical study at renowned Monash University, in Melbourne, Australia.

January 19, 2022
·
3 min read
Policy

Omeros Confirms Submission of Response to FDA Regarding the BLA for Narsoplimab in the Treatment of HSCT-TMA

Omeros Corporation confirmed that earlier this month the company submitted to the U.S. Food and Drug Administration its response to the Agency’s Complete Response Letter for narsoplimab in the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy.

January 19, 2022
·
3 min read
Drug Development

New England Journal of Medicine Publishes Data from ECOSPOR lll Phase 3 Study Evaluating Investigational Microbiome Therapeutic SER-109 in Recurrent C. Difficile Infection

Seres Therapeutics, Inc., a leading microbiome therapeutics company, announced the publication in the New England Journal of Medicine of data from its Phase 3 ECOSPOR III study evaluating SER-109, an investigational oral microbiome therapeutic for the treatment of recurrent C. difficile infection.

January 19, 2022
·
6 min read